These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25808961)

  • 21. Using 68 Ga-DOTATATE PET for Postoperative Radiosurgery and Radiotherapy Planning in Patients With Meningioma: A Case Series.
    Hintz EB; Park DJ; Ma D; Viswanatha SD; Rini JN; Schulder M; Goenka A
    Neurosurgery; 2023 Jul; 93(1):95-101. PubMed ID: 36722951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved Detection of Postoperative Residual Meningioma with [
    Bashir A; Larsen VA; Ziebell M; Fugleholm K; Law I
    Clin Cancer Res; 2021 Apr; 27(8):2216-2225. PubMed ID: 33526423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 68Ga-DOTATOC-PET/CT-guided resection of a primary intraosseous meningioma: technical note.
    Guinto-Nishimura GY; Gómez-Amador JL; Kerik-Rotenberg N; Uribe-Pacheco R; Sangrador-Deitos MV; Martínez-Manrique JJ
    Neurosurg Focus; 2021 Jan; 50(1):E6. PubMed ID: 33386007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
    Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B
    Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas.
    Khoo VS; Adams EJ; Saran F; Bedford JL; Perks JR; Warrington AP; Brada M
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1309-17. PubMed ID: 10725645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas.
    Ivanidze J; Chang SJ; Haghdel A; Kim JT; Roy Choudhury A; Wu A; Ramakrishna R; Schwartz TH; Cisse B; Stieg P; Muller L; Osborne JR; Magge RS; Karakatsanis NA; Roytman M; Lin E; Pannullo SC; Palmer JD; Knisely JPS
    Neuro Oncol; 2024 Aug; 26(8):1526-1535. PubMed ID: 38553990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.
    Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC
    J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Cancer Metastasis Mimicking Meningioma in 68Ga-DOTATOC PET/CT.
    Fabritius MP; Geyer T; Ahmaddy F; Albert NL; Bartenstein P; Tiling R; Rübenthaler J; Holzgreve A
    Clin Nucl Med; 2021 Nov; 46(11):922-923. PubMed ID: 34132678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canine meningiomas treated with three-dimensional conformal radiation therapy require magnetic resonance imaging to avoid a geographic miss.
    Berlato D; Zwingenberger AL; Ruiz-Drebing M; Pradel J; Clark N; Kent MS
    Vet Radiol Ultrasound; 2018 Nov; 59(6):777-785. PubMed ID: 29956402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Astner ST; Adam M; Krause BJ; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):339-44. PubMed ID: 16765533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
    Kreissl MC; Hänscheid H; Löhr M; Verburg FA; Schiller M; Lassmann M; Reiners C; Samnick SS; Buck AK; Flentje M; Sweeney RA
    Radiat Oncol; 2012 Jun; 7():99. PubMed ID: 22720902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved target volume definition for precision radiotherapy planning of meningiomas by correlation of CT and dynamic, Gd-DTPA-enhanced FLASH MR imaging.
    Schad LR; Blüml S; Debus J; Scharf J; Lorenz WJ
    Radiother Oncol; 1994 Oct; 33(1):73-9. PubMed ID: 7878213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of [
    Wang P; Liu S; Li X; Liu X; Li S; Wu Z; Cheng X
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):218-225. PubMed ID: 37682301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric 18F-FDG and 68GA-DOTATOC PET Imaging in Bone Metastatic Meningioma Before Radionuclide Therapy: Assessment of Tumor Heterogeneity.
    Mairal E; Chevalier E; Imbert L; Boursier-Joppin C; Verger A
    Clin Nucl Med; 2022 Mar; 47(3):e321-e322. PubMed ID: 35044963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
    Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
    Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.
    van Essen M; Krenning EP; Kooij PP; Bakker WH; Feelders RA; de Herder WW; Wolbers JG; Kwekkeboom DJ
    J Nucl Med; 2006 Oct; 47(10):1599-606. PubMed ID: 17015894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative [
    Teske N; Biczok A; Quach S; Dekorsy FJ; Forbrig R; Bodensohn R; Niyazi M; Tonn JC; Albert NL; Schichor C; Ueberschaer M
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):206-217. PubMed ID: 37642702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.